MetaCap

Alamar Biosciences (ALMR) vs Harvard Bioscience (HBIO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Alamar Biosciences is the larger company by market cap ($1.84 billion vs $39.6 million), about 46.5 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ALMR+20.36%HBIO+41.27%
+78%+27%-23%
Apr 17, 20261 yearNov 20, 2026
ALMR+20.36%HBIO+41.27%
+62%+22%-18%
Apr 13, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ALMR versus HBIO key metrics
MetricALMRHBIO
Share price$26.48$8.66
Market cap$1.84B$39.60M
1-day change-7.67%-0.23%
YTD return—+29.25%
1-year return—+37.46%
5-year return—-87.45%
Forward P/E—16.34
EPS (TTM)$-1.13$-2.59
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$86.55M
Revenue growth (YoY)—-8.06%
Net income (latest FY)—$-56.70M
Gross margin—57.67%
Operating margin—-56.13%
Net margin—-65.51%
52-week high$39.61$10.20
52-week low$18.85$4.00
Distance from 52-week high-33.15%-15.10%
Analyst consensusbuynone
Avg. price target upside+39.73%-13.39%
Average volume628.70K21.82K
Shares outstanding69.48M4.57M
Employees308316
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Alamar Biosciences is about 46.5 times larger than Harvard Bioscience by market value ($1.84B vs $39.60M).

About Alamar Biosciences

ALMR stock →

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.

Industrials · Biotechnology: Laboratory Analytical Instruments · 308 employees

About Harvard Bioscience

HBIO stock →

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.

Industrials · Biotechnology: Laboratory Analytical Instruments · 316 employees

ALMR vs HBIO FAQ

Which is bigger, Alamar Biosciences or Harvard Bioscience?

Alamar Biosciences (ALMR) is larger, with a market capitalization of $1.84B compared with $39.60M for Harvard Bioscience (HBIO).

Are Alamar Biosciences and Harvard Bioscience in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons